|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01139827 |
|
Date of registration:
|
08/06/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
September 2009 |
|
Target sample size:
|
178 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01139827 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Cross-Sectional
|
|
|
Countries of recruitment
|
|
Korea, Republic of
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- healthy subjects
Exclusion Criteria:
- a history of cardiovascular disease (myocardial infarction, unstable angina, stroke
or cardiovascular revascularization)
- active inflammatory disease, recent active infection
- stage 2 hypertension (resting blood pressure, = 160/100 mmHg)
- diabetes mellitus
- systemic disorders such as severe hepatic, renal, and hematologic diseases
- taking drugs known to interfere with vascular inflammation measured by FDG-PET.
Age minimum:
16 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Cardiovascular Risk
|
|
Secondary ID(s)
|
|
PET(FRS-CRP)
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|